We are amidst a paradigm shift in obesity treatment, spurred by the introduction of newer, highly effective anti-obesity medications. While interest in treatment is higher than ever, we are faced with significant challenges and evidence gaps around efficacy, safety, and costs of care, that will make the next 5-10 years a tumultuous period, with rapidly changing formularies, best practices, and preferred treatments. How are large health systems responding to the current challenges, and what can we do now to help ensure the greatest access to effective treatment? Let’s explore together how one large integrated system is rising to the challenge of optimizing obesity care for the future.

CME/CE Expiration Date: 4/26/27

*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.